Peer-reviewed articles

Botta L, Matsuda T, Charvat H, et al. Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure. Front Oncol. 2023;13:1219111. doi:10.3389/fonc.2023.1219111

Matz M, Valkov M, Šekerija M, et al. Worldwide trends in esophageal cancer survival, by sub?site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000?2014 (CONCORD?3). Cancer Communications. 2023;43(9):963-980. doi:10.1002/cac2.12457

Lopez-Cortes A, Didonè F, Botta L, et al. Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project - international benchmarking of childhood cancer survival by stage. Front Oncol. 2023;13:1232451. doi:10.3389/fonc.2023.1232451

Conlon E, Fitzgerald C, Hintze J, et al. High frequency and mortality of head and neck malignancy in organ transplant recipients in Ireland - A national cohort study. Am J Otolaryngol. 2023;44(4):103827. doi:10.1016/j.amjoto.2023.103827

O'Reilly S, Kathryn Carroll H, Murray D, et al. Impact of the COVID-19 pandemic on cancer care in Ireland - Perspectives from a COVID-19 and Cancer Working Group. J Cancer Policy. 2023;36:100414. doi:10.1016/j.jcpo.2023.100414

Cabasag CJ, Arnold M, Rutherford M, et al. Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study. Int J Cancer. 2023;152(9):1763-1777. doi:10.1002/ijc.34403

Demuru E, Rossi S, Ventura L, et al. Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes. Front Oncol. 2023;13:1114701. doi:10.3389/fonc.2023.1114701

Girardi F, Matz M, Stiller C, et al. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3). Neuro-Oncology. 2023;25(3):580-592. doi:10.1093/neuonc/noac217

Girardi F, Di Carlo V, Stiller C, et al. Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3). Neuro-Oncology. 2023;25(3):593-606. doi:10.1093/neuonc/noac232

Sexton GP, Walsh P, Moriarty F, O'Neill JP. Age Alone Is Not a Barrier to Concurrent Chemoradiotherapy for Advanced Head and Neck Cancer. Ann Otol Rhinol Laryngol. 2023;132(3):275-283. doi:10.1177/00034894221086087

Doyle C, Brennan A, Wolinska A, et al. Incidence of Merkel cell carcinoma in the Republic of Ireland (1994-2019). International Journal of Dermatology. 2023;62(8). doi:10.1111/ijd.16661

Morgan E, O'Neill C, Bardot A, Walsh P, Soerjomataram I, Arnold M. The Challenges of Collecting Long-Term Outcomes in Cancer Patients on the Population-Level: The Case of Metastatic Breast Cancer. J Registry Manag. 2023;50(4):173-175.

Botta L, Gatta G, Capocaccia R, et al. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study. Lancet Oncol. 2022;23(12):1525-1536. doi:10.1016/S1470-2045(22)00637-4

Botta L, Gatta G, Didonè F, Lopez Cortes A, Pritchard-Jones K, the BENCHISTA Project Working Group. International benchmarking of childhood cancer survival by stage at diagnosis: The BENCHISTA project protocol. Tiao G, ed. PLoS ONE. 2022;17(11):e0276997. doi:10.1371/journal.pone.0276997

Nikši? M, Matz M, Valkov M, et al. World-wide trends in net survival from pancreatic cancer by morphological sub-type: An analysis of 1,258,329 adults diagnosed in 58 countries during 2000-2014 (CONCORD-3). Cancer Epidemiology. 2022;80:102196. doi:10.1016/j.canep.2022.102196

Cardoso R, Guo F, Heisser T, et al. Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries. Lancet Reg Health Eur. 2022;21:100458. doi:10.1016/j.lanepe.2022.100458

Sharkey Ochoa I, O'Regan E, Toner M, et al. The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2022;14(17). doi:10.3390/cancers14174321

Di Carlo V, Stiller CA, Eisemann N, et al. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3). British Journal of Dermatology. 2022;187(3):364-380. doi:10.1111/bjd.21274

Cardoso R, Guo F, Heisser T, et al. Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study. Lancet Gastroenterol Hepatol. 2022;7(8):711-723. doi:10.1016/S2468-1253(22)00084-X

Arnold M, Morgan E, Bardot A, et al. International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study). Gut. 2022;71(8):1532-1543. doi:10.1136/gutjnl-2021-325266

Vener C, Rossi S, Minicozzi P, et al. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials. Front Oncol. 2022;12:892684. doi:10.3389/fonc.2022.892684

Ssenyonga N, Stiller C, Nakata K, et al. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. The Lancet Child & Adolescent Health. 2022;6(6):409-431. doi:10.1016/S2352-4642(22)00095-5

Sexton GP, Walsh P, Moriarty F, O'Neill JP. The changing face of Irish head and neck cancer epidemiology: 20 years of data. Eur Arch Otorhinolaryngol. 2022;279(6):3079-3088. doi:10.1007/s00405-021-07118-4

Menzies S, O'Leary E, Callaghan G, et al. A population-based comparison of organ transplant recipients in whom cutaneous squamous cell develops versus those in whom basal cell carcinoma develops. J Am Acad Dermatol. 2022;86(6):1377-1379. doi:10.1016/j.jaad.2021.05.032

Anderson S, Breen KJ, Davis NF, Deady S, Sweeney P. Penile cancer in Ireland - A national review. Surgeon. 2022;20(3):187-193. doi:10.1016/j.surge.2021.04.004